The Oral Proteins And Peptides Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Oral Proteins And Peptides Market?
The market size for oral proteins and peptides has seen significant growth recently. It was projected to increase from $1.27 billion in 2024 to $1.56 billion in 2025, with a compound annual growth rate (CAGR) of 22.7%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Oral Proteins And Peptides Industry?
The Oral Proteins And Peptides Global Market Report 2025 predicts that by 2029, the market size will reach $3.49 billion, growing at a compound annual growth rate (CAGR) of 22.3%.
Download Your Free Sample of the 2025 Oral Proteins And Peptides Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Oral Proteins And Peptides Market?
The key drivers in the oral proteins and peptides market are:
• Increasing focus on patient-centric drugs
• Growing prevalence of the geriatric population
• Rising healthcare expenditure
• A rising preference for oral drugs
Global Market Segmentation: Identifying Major Oral Proteins And Peptides Industry Segments
The oral proteins and peptidesmarket covered in this report is segmented –
1) By Drug Type: Linaclotide, Calcitonin, Insulin, Plecanatide, Octreotide
2) By Biological Target: Guanylate Cyclase-C (GC-C), Insulin Receptor, Oxalate, Other Biological Targets
3) By Mechanism Of Action: Receptor Stimulation, Substrate Degradation, Other Mechanisms Of Action
4) By Application: Gastrointestinal Disorders, Bone Disease, Neurological Disorders, Diabetes, Metabolic Disorders, Hormonal Disorder, Cancer
Pre-order the 2025 Oral Proteins And Peptides Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Oral Proteins And Peptides Market?
The key trends in the oral proteins and peptides market are:
• The development of novel oral peptides with enhanced stability and efficacy is a major emerging trend.
• There is an ongoing trend of integrating artificial intelligence in drug development processes for oral formulations.
• Advanced medical treatments are also trending, shaping the future of the industry.
• Innovations in oral insulin formulations and advancements in drug delivery technologies are key future trends.
Who Are the Top Competitors & Leading Players in the Oral Proteins And Peptides Market?
Major companies in the oral proteins and peptides market are:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• Roche Holding AG
• Merck & Co. Inc.
• AbbVie Inc.
• Sanofi S.A.
• AstraZeneca PLC
• Novartis AG
• GlaxoSmithKline PLC
• Eli Lilly and Company
• Amgen Inc.
• Novo Nordisk A/S
• Ipsen S.A.
• Biocon Limited
• Xeris Pharmaceuticals Inc.
• Adocia S.A.
• Zealand Pharma A/S
• Diabetology Ltd.
• Oramed Pharmaceuticals Inc.
• Palatin Technologies Inc.
• Entera Bio Ltd.
Regional Dominance: Which Area Leads the Global Oral Proteins And Peptides Market?
North America was the largest region in the oral proteins and peptides market in 2024
